ACETAMINOPHEN
- Product NDC
- 70010-160
- 11-digit product format
- 700100160
- Labeler code
- 70010
- Product ID
- 70010-160_451b5125-968f-8c11-e063-6294a90a447c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Granules Pharmaceuticals Inc.
- Application
- ANDA211544
- Marketing category
- ANDA
- Marketing start
- 2022-02-15
- Substance
- ACETAMINOPHEN
- Active strength
- 650 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ACETAMINOPHEN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAMINOPHEN | 650 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 362O9ITL9D |
| Rxcui | 1148399 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70010-160-01 | ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70010-160 | ACETAMINOPHEN TABLET, EXTENDED RELEASE [GRANULES PHARMACEUTICALS INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20230129_d5352861-6926-f1b0-e053-2a95a90a7d66.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70010-160-01 | 70010016001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-160-01) | 2022-02-15 | 0000-00-00 | No | No | Current |